Table 2.

Expected benefits and demographic/clinical variables

	Number	Expected benefit
		Mean (SD)	P value
Age (years)
> 65	306	57.6 (19.7)	< 0.001
56–65	302	62.1 (17.7)
≤ 55	356	65.5 (19.3)
Gender
Male	354	56.3 (19.2)	< 0.001
Female	610	65.2 (18.5)
Race
White	758	61.8 (19.3)	0.76
Non-white	205	62.3 (18.8)
Education
High school or less	246	57.3 (18.6)	< 0.001
College or above	716	63.5 (19.2)
Marital status
Not married	292	61.6 (19.1)	0.70
Married/living with partner	654	62.1 (19.4)
Cancer type
Breast	315	67.9 (17.6)	< 0.001
Gastrointestinal	313	59.4 (18.9)
Lung	293	58.9 (19.7)
Other	42	57.1 (19.6)
Cancer stage
Localized disease	524	62.3 (19.5)	0.49
Metastatic disease	431	61.5 (19.0)
Surgery
No	354	59.8 (18.2)	0.011
Yes	605	63.1 (19.7)
Radiation
No	501	62.2 (18.6)	0.62
Yes	458	61.6 (20.0)
Chemotherapy
No	141	62.2 (20.3)	0.85
Yes	818	61.9 (19.1)
Months since diagnosis
≤ 12 months	432	59.8 (20.0)	0.0071
> 12 and ≤ 36 months	240	63.3 (19.3)
> 36 months	281	64.0 (17.7)
Family support
No	659	56.5 (17.7)	< 0.001
Yes	302	73.6 (17.0)

Statistically significant p values highlighted in italic numbers